{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P05305",
      "entity_text" : "endothelin-1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0079" ],
      "CellLine" : [ "cellosaurus:CVCL_0062" ],
      "Organ" : [ "uberon:UBERON:0000105" ],
      "Species" : [ "taxonomy:9606" ],
      "CellType" : [ "cl:CL:0000233" ]
    }
  },
  "verbose_text" : "During early stages of tumor progression concurrent use of CORM-A1 and DETA/NO demonstrated vasoprotective ability (decreased endothelin-1, sICAM and sE-selectin plasma level) and downregulated platelets activation (decreased bound of fibrinogen and vWf to platelets) as well as inhibited EMT process.",
  "reading_complete" : "2020-08-02T10:53:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T10:51:55Z",
  "trigger" : "level",
  "evidence" : [ "endothelin-1, sICAM and sE-selectin plasma level" ],
  "pmc_id" : "6587338",
  "score" : 0
}